Sheffield Institute for Translational Neuroscience SITraN is an essential development in the fight against motor neurone disease, other common neurodegenerative disorders, stroke and neuroinflammatory conditions. You are here Home Sheffield Institute for Translational Neuroscience Photo of Queen Elizabeth II visiting SITraN in 2010 About SITraN Our impact Our research Study with us Facilities News 29 November 2022 MS patients could be offered stem cell transplants as a first-line treatment in new world-first trial A world-first trial is investigating if stem cell transplantation could be used in patients with aggressive multiple sclerosis (MS) as a first-line treatment. NIHR Sheffield Biomedical Research Centre 21 September 2022 Promising MND drug helps slow disease progression and benefits patients physically Scientists believe a new genetically-targeted therapy to treat motor neurone disease (MND) could be a turning point for patient care, after the results of a Phase 3 clinical trial showed significant physical benefits for patients after 12 months. 21 June 2022 Sheffield scientists benefit from £4.25 million to kick start MND research institute Researchers from the University of Sheffield’s Institute for Translational Neuroscience (SITraN) have been awarded part of a new £4.25 million grant that seeks to discover meaningful MND treatments within years, not decades. 14 June 2022 New research identifies more than 1,000 genes linked to severe COVID-19 Researchers from the University of Sheffield and Stanford University in the US have discovered there are specific genetic signals in people who develop severe coronavirus infection. View all SITraN news